ALTERNATING CHIVPP PAB1OE IS BETTER THAN PAB1OE ALONE AS INITIAL CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE (HD) - FIRST RESULTS OF A BRITISH NATIONAL LYMPHOMA INVESTIGATION (BNLI)/CENTRAL LYMPHOMA GROUP (CLG)STUDY/

Authors
HANCOCK BW CULLEN MH HUDSON GV
Citation
Bw. Hancock et al., ALTERNATING CHIVPP PAB1OE IS BETTER THAN PAB1OE ALONE AS INITIAL CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE (HD) - FIRST RESULTS OF A BRITISH NATIONAL LYMPHOMA INVESTIGATION (BNLI)/CENTRAL LYMPHOMA GROUP (CLG)STUDY/, European journal of cancer, 33, 1997, pp. 1186-1186
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
1186 - 1186
Database
ISI
SICI code
0959-8049(1997)33:<1186:ACPIBT>2.0.ZU;2-2